Modisal Xl (Isosorbide Mononitrate)

Isosorbide mononitrate is used in the management of coronary artery disease‑related conditions, primarily targeting angina.

• Angina pectoris: reduces frequency and severity of chest pain episodes by decreasing myocardial oxygen demand.
• Chronic stable angina: improves exercise tolerance and prevents angina attacks during physical activity.

• Isosorbide mononitrate is metabolized to release nitric oxide, which activates guanylate cyclase in vascular smooth muscle. The resulting increase in cyclic guanosine monophosphate (cGMP) leads to relaxation of arterial and venous vessels, lowering preload and afterload, and thereby decreasing myocardial oxygen consumption. The effect is dose‑dependent and persists with once‑daily dosing, providing sustained vasodilation without significant tachyphylaxis. Because it does not require enzymatic conversion by aldehyde dehydrogenase, its activity is less affected by hepatic impairment.

Isosorbide mononitrate may cause a range of adverse reactions, which are classified by frequency and severity.

Common Side Effects

• Headache: throbbing pain often occurring shortly after dosing.
• Dizziness or light‑headedness: due to transient blood pressure reduction.
• Flushing: warm sensation and reddening of the skin.
• Nausea: mild gastrointestinal upset.

Serious or Rare Side Effects

• Severe hypotension: marked drop in blood pressure leading to fainting.
• Syncope: sudden loss of consciousness associated with vasodilation.
• Allergic reactions: rash, itching, swelling, or anaphylaxis in rare cases.

When prescribing or dispensing Modisal Xl, consider the following precautions to ensure safe use.

• Discontinue abruptly: sudden stop may precipitate rebound angina; tapering is recommended.
• Monitor blood pressure: check for hypotension especially after dose initiation.
• Concomitant PDE‑5 inhibitors: avoid co‑administration due to risk of profound hypotension.
• Hepatic impairment: use with caution as metabolism may be altered.
• Pregnancy and lactation: safety not established; avoid unless benefits outweigh risks.
• Store at ambient temperature: keep below 25 °C in original packaging, protected from moisture.

Isosorbide mononitrate interacts with several medicines; awareness of these interactions helps prevent adverse events.

Major Interactions (Avoid)

• Other nitrates (e.g., nitroglycerin): additive vasodilation can cause severe hypotension.
• Phosphodiesterase‑5 inhibitors (e.g., sildenafil): may lead to dangerous blood pressure drops.
• Alcohol: excessive intake can enhance hypotensive effects.

Moderate Interactions (Monitor Closely)

• Antihypertensive agents (e.g., ACE inhibitors, beta‑blockers): may increase blood‑pressure‑lowering effect.
• Diuretics: can cause volume depletion and accentuate hypotension.
• Azole antifungals (e.g., ketoconazole): may raise plasma levels of isosorbide mononitrate.